What do we need to make genetic biomarker-guided treatment for renal cell carcinoma a reality?

Meta H. DIekstra; Xiaoyan Liu; Jesse J. Swen; Henk Jan Guchelaar

doi:10.2217/pgs-2016-0168

What do we need to make genetic biomarker-guided treatment for renal cell carcinoma a reality?

Meta H. DIekstra
, Xiaoyan Liu
, Jesse J. Swen
, Henk Jan Guchelaar

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-4
Number of pages	4
Journal	Pharmacogenomics
Volume	18
Issue number	1
DOIs	https://doi.org/10.2217/pgs-2016-0168
Publication status	Published - Jan 2017
Externally published	Yes

Keywords

biomarker
pharmacogenetics
renal cell carcinoma
SNP
targeted therapy

Access to Document

10.2217/pgs-2016-0168

Cite this

@article{08b15f13eb4f44a3b77e5b3e6fbfaeeb,

title = "What do we need to make genetic biomarker-guided treatment for renal cell carcinoma a reality?",

keywords = "biomarker, pharmacogenetics, renal cell carcinoma, SNP, targeted therapy",

author = "DIekstra, \{Meta H.\} and Xiaoyan Liu and Swen, \{Jesse J.\} and Guchelaar, \{Henk Jan\}",

year = "2017",

month = jan,

doi = "10.2217/pgs-2016-0168",

language = "English",

volume = "18",

pages = "1--4",

journal = "Pharmacogenomics",

issn = "1462-2416",